Trials / Recruiting
RecruitingNCT06378944
Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
INDOCYANINE GREEN for SELECTIVE SENTINELLA AXILLARY LYMPH NODE BIOPSY in PATIENTS with BREAST CANCER
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 15,000 (estimated)
- Sponsor
- Omphis Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
Detailed description
In the operating room 1 ml of indocyaninge grenn will be injectec periareolar . After 5 minutes the lymph node will be detected and extracted. The comparison between the lymph nodes detected with Technetium 99 and indocyanine green will be analysed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Application of green indocyanine colorant | The day of the surgery 1 ml of green indocyanine colorant will be applicated periareolar. After 5 minutes the lymph node will be detected and extracted |
| DRUG | Technetium99 | Application of a periareolar injectionof TEchnetium 99 in order to detect the axillary lymph node |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2029-01-01
- Completion
- 2029-01-01
- First posted
- 2024-04-23
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06378944. Inclusion in this directory is not an endorsement.